IPO activity continued at a record pace this past week with 19 IPOs, marking the fourth week in 2021 with at least 17 US IPOs, the most since the year 2000. With the August lull around the corner, the pipeline saw less activity than usual; five IPOs and 13 SPACs...read more
Cytek BioSciences, which provides cell analysis instruments for life science applications, raised $285 million by offering 16.7 million shares (30% secondary) at $17, within the range of $16 to $18. The offering contained 2.2 million more shares than anticipated...read more
Cytek BioSciences, which provides cell analysis instruments for life science applications, announced terms for its IPO on Monday.
The Fremont, CA-based company plans to raise $248 million by offering 14.6 million shares (19% insider) at a price range of $16...read more
Cytek BioSciences, which provides cell analysis instruments for life science applications, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Cytek Biosciences' core products are the Aurora and Northern Lights systems,...read more
US IPO Weekly Recap: Life sciences, software, and more ride the summer wave in a 19 IPO week
IPO activity continued at a record pace this past week with 19 IPOs, marking the fourth week in 2021 with at least 17 US IPOs, the most since the year 2000. With the August lull around the corner, the pipeline saw less activity than usual; five IPOs and 13 SPACs...read more
Cell analysis instruments provider Cytek BioSciences prices upsized IPO at $17 midpoint
Cytek BioSciences, which provides cell analysis instruments for life science applications, raised $285 million by offering 16.7 million shares (30% secondary) at $17, within the range of $16 to $18. The offering contained 2.2 million more shares than anticipated...read more
Cell analysis instruments provider Cytek BioSciences sets terms for $248 million IPO
Cytek BioSciences, which provides cell analysis instruments for life science applications, announced terms for its IPO on Monday. The Fremont, CA-based company plans to raise $248 million by offering 14.6 million shares (19% insider) at a price range of $16...read more
Cell analysis instruments provider Cytek BioSciences files for a $100 million IPO
Cytek BioSciences, which provides cell analysis instruments for life science applications, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Cytek Biosciences' core products are the Aurora and Northern Lights systems,...read more